CRISPR-Cas9-guided amplification-free genomic diagnosis for familial hypercholesterolemia using nanopore sequencing.
Xu S, Shiomi H, Yamashita Y, Koyama S, Horie T, Baba O, Kimura M, Nakashima Y, Sowa N, Hasegawa K, Suzuki A, Suzuki Y, Kimura T, Ono K.
Xu S, et al. Among authors: yamashita y.
PLoS One. 2024 Mar 20;19(3):e0297231. doi: 10.1371/journal.pone.0297231. eCollection 2024.
PLoS One. 2024.
PMID: 38507394
Free PMC article.